We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Firms Must Balance Risks vs. Benefits In Social Media Info, U.S. FDA Says
Firms Must Balance Risks vs. Benefits In Social Media Info, U.S. FDA Says
Devicemakers using Twitter to promote their products need to include both product benefit and risk information in every tweet, despite the 140-character limitation that Twitter imposes on messages, the U.S. Food and Drug Administration says.
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor